Fortunately, this invariably fatal diseasemotor neurone diseaseis not common. In Europe and North America, the death rate appears to be about one per 100,000 of the population. It is commoner than myasthenia gravis but not nearly so common as multiple sclerosis. Death usually follows in from one to three years, but there are exceptions. Amyotrophic lateral sclerosis is commoner in the male (3 male to 1 female), but bulbar palsy is probably commoner in the female (2 female to 1 male). A family history of the disease is unusual, probably no more than 6 % in most European series. In the majority of cases diagnosis is not difficult. The illness commonly begins with weakness in the small muscles of the hand, muscular atrophy and fasciculation are present and the arm reflexes are hyperactive. The painless nature of the complaint and the negative sensory examination usually enable the clinician to exclude other causes of wasting of the hand muscles such as ulnar nerve lesions, the carpal tunnel syndrome and cervical spondylosis. In the last named condition, fasciculation is rarely as widespread as in motor neurone disease, muscular tenderness, pain and paresthesix may be noted, and the pattern of reflex activity in the affected upper limb may indicate a mid-cervical cord lesion. A bilateral chronic ulnar palsy may be insidious in development, without pain or tenderness at the elbow, and the characteristic sensory impairment may pass unnoticed by the patient.
However, there are patients with motor neurone disease in whom the true nature of the complaint may not be readily recognized. This may be the case, for example, when wasting and weakness of the anterior tibial group of muscles in one lower limb is the presenting feature. A flaccid foot drop with a feeling of heaviness and aching about the foot and ankle in a middle-aged person may be difficult to identify as the first 61 manifestation of motor neurone disease. A similar disturbance arising in the opposite leg may raise the question of a cauda equina syndrome. This type of case, without any pyramidal disorder, may progress slowly and I have known such cases continue for as long as six years. A slowly progressive spastic weakness of one lower limb may also be the first manifestation of amyotrophic lateral sclerosis. The absence of muscular wasting and fasciculation may for a time obscure the diagnosis and necessitate much investigation. Another mode of onset in which diagnostic difficulties may be encountered is that where weakness begins in the tongue and remains confined there for some time. If fasciculation is present, the characteristic vermicular movements can usually be recognized if the tongue is allowed to remain in the floor of the mouth in a relaxed fashion with the mouth open. The muscular contraction of the protruded tongue may mask fasciculation. A brisk jaw-jerk and electromyographic evidence of fasciculationin lower facial and neck muscles may clinch the diagnosis. An important differential diagnosis in this early bulbar type of case is from myasthenia gravis. There may be no fatigue phenomenon which can be elicited from the clinical history in some cases of myasthenia gravis, the response to a Prostigmin or Tensilon test is not always obvious, and occasionally, fasciculation of tongue musculature is seen in myasthenia gravis. As bulbar palsy in motor neurone disease progresses, some degree of selectivity in muscle involvement becomes evident. The muscles of the upper face and eyeballs are rarely involved. The tongue may be paralysed when the sternomastoid muscles remain intact. Articulation may be grossly affected although swallowing remains practically normal.
When muscular weakness and wasting begins, not in one or both hands, but about the shoulder girdles, especially in fat people in whom fasciculation is hidden, the diagnosis may not be obvious.
With progressive weakness of the deltoid muscles, the patient may complain of aching in the shoulder and numbness in the hands with swelling of his fingers. The arms tend to hang limply at the sides and if stiffness has developed in a shoulder then this, together with the pain and discomfort especially experienced in bed at night, may lead to a diagnosis of some form of arthritis or rheumatism.
Dementia preceding the symptoms and signs of motor neurone disease, I have observed in two patients only. In the first, a woman aged 55, air encephalography demonstrated the characteristic features of cerebral atrophy, but eighteen months later wasting and weakness of the right hand muscles made their appearance and the course of her disease was otherwise typical. In the second case both the wasting and the dementia developed simultaneously.
One recent and unusual mode of presentation was that of a miner with moderate pneumoconiosis. On neurological examination his shortness of breath proved to be due to increasing weakness of his respiratory muscles and involvement of upper limbs soon followed. In these cases presenting problems in diagnosis, there is the question of elevated cerebrospinal fluid protein. In the majority of cases there is no abnormality in the spinal fluid, but occasionally the protein content may be significantly raised. I have seen a few cases in which it has reached 100 mg/ 100 ml. I do not recall having seen motor neurone disease in a patient who has suffered from poliomyelitis or epidemic encephalitis. Neither have I noticed it in patients following gastrectomy as reported by Ask-Upmark. In one case of an islet cell tumour of the pancreas the presenting feature was weakness of both shoulder girdle groups of muscles. But the onset was fairly acute and although accompanied by fasciculation there was a long story of episodic disturbance of consciousness with abnormal behaviour. Genetic Aspects I think it unlikely that there would be a genetical contribution to this discussion were it not for the recent interest in the endemic variety of motor neurone disease on the island of Guam. I say 'variety' for it is evident that most diseases which are genetically determined are in fact genetically heterogeneous, and this is certainly the situation with motor neurone disease.
The prevalence rate of motor neurone disease in several countries is about 4 per 100,000, whereas in Guam it is about 200 or more per 100,000, due to a high incidence in the Chamorros, in whom it accounts for about 10% of all deaths in adult life. The early reports suggested that clinically and pathologically the disease was identical with classical motor neurone disease, but more recent reports (Hirano, Kurland, Krooth & Lessell 1961; Hirano, Malamud & Kurland 1961 ) on the so-called parkinsonism-dementia complex suggest that the disease may show itself as parkinsonism with dementia, with or without motor neurone disease, or as a clinically pure motor neurone disease.
The occurrence of these differing clinical pictures in more than one member of the same family, and the similar age at onset and rate of progression, suggest that they have the same etiological basis. Genetic investigations have been hampered by the destruction of records and by the Japanese occupation of the islands, and it is not certain what is the mode of inheritance or, indeed, if it is truly genetically determined. The crucial observation may well come from a longterm study (Torres et al. 1957 ) of the 1,000 Chamorros who have settled in California, a few at the end of the last century, about one hundred before 1940 and the remainder since 1950. Of 165 interviewed recently, 2 developed the disease at the age of 40, having left Guam at the age of 22. Of perhaps greater significance, though medically unconfirmed, is the report of 2 brothers who left the island aged 17 and who developed the disease at the age of 50. At present, the evidence is insufficient to decide between a largely genetic atiology and an environmental factor, although this has been sought and not found. Possibly there may be some environmental factor acting in childhood, as has been suggested recently for disseminated sclerosis.
The pedigrees from Guam led to the collection and analysis (Kurland & Mulder 1955 ) of pedigrees in which several members have suffered from a disease resembling motor neurone disease. One of the earliest and best known of these is a disorder in the Farr family of Vermont, originally reported by Osler. These families differ sharply from the classical motor neurone disease in the pronounced familial incidence, often extending over three or more generations, and they often show unusual features in an individual family, whether this be a prolonged course over twenty years, a combination with features of parkinson-ism or an atypical distribution of lesions at autopsy. In these pedigrees, inheritance is usually dominant, and the group is almost certainly genetically heterogeneous. It is appropriate here to recall the remarkable Drew family, reported in 1929 by Ferguson & Critchley, in which problems of this kind were exemplified.
Yet a further group is childhood motor neurone disease, as represented by the 2 sisters reported in 1905 by Gordon Holmes, with onset at the age of 2 and slow progression, up to the age of 30, of familial spastic paralysis associated with amyotrophy. A similar picture of later onset has also been fairly frequently reported.
Of perhaps more claim to be a homogeneous group is the juvenile familial benign form of spinal muscular atrophy (Kugelberg & Welander 1956) , with onset in childhood or adolescence, slow progression, and probably recessively determined. Its relationship to motor neurone disease on the one hand, and to Werdnig-Hoffmann disease on the other hand, will only become clear when the pathogenesis of these diseases is better understood.
Finally, there is classical motor neurone disease in which a positive family history is unusual. Some series of patients, in one instance numbering 190, have been reported in which no relative is known to have been affected. In other series, about 3 to 6 %, or even up to 15 %, of patients are reported to have an affected relativea sib more frequently than a parent.
There are, unfortunately, few series in which the numbers of affected and unaffected sibs and parents are recorded, together with a routine enquiry into parental consanguinity. Such figures, together with an estimate of the incidence and prevalence in the general population, are essential for the assessment of the genetic factor in classical motor neurone disease. The genetic factor appears to be of considerably less importance than in the other four groups which I have discussed. Pathological Aspects Greenfield (1958) pointed out that the pathology of amyotrophic lateral sclerosis is not confined to the motor nerve cells and their axons: the spinocerebellar and rubrospinal tracts are commonly involved and also the spinoreticular fibres, the myelinated fibres in the anterior horn, the anterior commissure, the ansa reticularis and the middle third of the corpus callosum, all of which must be taken into account in any attempt to explain the nature of this disease. The anatomical features have been reviewed by Colmant (1958) .
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The central morphological feature of the disease, however, is the degeneration of the motor cells and it may take the form of lipopigmentary atrophy or simple atrophy. Often the cells take on a characteristic oval shape with clumping of the Nissl substance, while at times one may see neuronophagia. Occasionally one finds unclassifiable forms of cell degeneration hard to interpret in terms of cell dysfunction. In Werdnig-Hoffmann disease, swelling of the anterior horn cells has been described of a type reminiscent of that seen in association with axonal degeneration.
Assessment of anterior horn cell population is often difficult, particularly with a paraffin section and in the sparsely populated thoracic cord; the pathologist is helped, therefore, ifhe sees abnormal nerve cells, an excess of glial nuclei or Holzerpositive gliosis. The loss of cells is usually greater in the posterolateral group than in the anteromesial group.
Because of their highly organized state, it is perhaps not unexpected that motor cells, and especially the larger ones, are vulnerable to a variety of factors. Syndromes resembling amyotrophic lateral sclerosis have been described frequently and perhaps it would be wiser to refer to such cases as 'motor neurone disease' using the term to include also amyotrophic lateral sclerosis.
They have been described in the course of mercury intoxication (Brown 1954 , Kantjarjian 1961 ), plumbism (Wilson 1907 , Cadwalader 1912 , Herrmann 1951 ) and after exposure to triorthocresyl phosphate (Scheid 1947 , Vogel 1947 , Mertens 1948 ) and to benzol (Ne'veril 1928) . Clinical evidence ofanterior horn cell involvement in manganese poisoning has been uncertain but the experimental work of van Bogaert & d'Allemagne (1945) suggests that these cells are affected directly rather than through the intermediary of a disordered liver. It could well be imagined that such toxins interfere with enzyme systems peculiar to motor cells or to their attendant glial cells (which cells may be more biochemically individualistic than we imagine). Nevertheless the syndrome of amyotrophic lateral sclerosis is uncommon in all these conditions and so it can be argued that an 'abiotrophic trait' has been brought to light in susceptible subjects by reason of the toxic substance.
Although the motor cells are vulnerable to histotoxic anoxia they are relatively resistant in states of anoxic or ischaemic anoxia. Recovery of function of the anterior horn cells has been observed experimentally after episodes of induced ischemia lasting fifteen minutes (Tureen 1936) and this is in marked contrast to the high degree of vulnerability of the small ganglion cells in lamina III and V. A comparable degree of robustness is displayed by the Betz cells in various forms of hypoxidosis.
Motor neurone disease has been described in association with certain metabolic and deficiency states, after gastric resection (Ask-Upmark 1950), for instance, and in hypoglycemia (Tom & Richardson 1951, Barris 1953 , Williams 1955 , Garland 1957 ) while it has been described in hyperthyroidism (Adams et al. 1953) , acromegaly (Adams et al. 1953) , in pregnancy (Notter & Savet 1949) , in vitamin E deficiency (Davison 1943 ) and in carcinoma (Brain & Henson 1958) . Dr Pallis and I have recently investigated a form of motor neurone disease with minimal involvement of the anterior horn cells in a case of longstanding urxmia. Some of these associations are rare and again may be the result of 'priming' of an abiotrophic trait: the association may even be fortuitous. The development of motor neurone disease in 4 out of a series of 111 patients after gastrectomy (Ask-Upmark 1950), however, suggests the workings of an acquired deficiency.
Motor neurones are known to be affected in association with spondylosis but Mair & Druckman (1953) in such cases demonstrated the ischemic causation of the anterior horn cell degeneration following pressure on the anterior spinal artery. Motor neurone disease has been described following trauma (Jeliffe 1935) including electrical injuries (Critchley 1934 , Panse 1955 .
The vulnerability of the motor cells in viral infections has been attributed to the avidity of some viruses, particularly poliovirus, for the ribosenucleic acid needed for their successful replication. Nowhere but in the nucleus of these highly organized and massive cells can such potential quantities be found. A chronic form of infection by the poliovirus was considered by Haddenbrock (1944) and motor neurone disease has been described following the acute disease (Geiger 1952 , Erbsloh 1958 . Neither of these conditions appears as yet to be well documented.
Spastic paraplegia with amyotrophy has been described after 'myelitis' (Leyden 1870) and after von Economo's disease (Wimmer & Neel 1928 , Lhermitte et al. 1938 . Opinions have varied as to whether those cases developing years after the latter disease are really true instances of amyotrophic lateral sclerosis, whether they are the result of chronic disease of the anterior horn cell initiated at the time of the original infection or whether they are caused by recent spread of the lurking virus to the affected cells. Recent experience with such a case makes us favour the view that we may be dealing with a continuing infection.
In instances of syphilitic paraplegia with amyotrophy, authorities have differed as to the relative importance of a burnt-out meningomyelitis on the one hand or, for want of a better term, this abiotrophic trend on the other hand. Martin (1925) once reminded us of the likely importance of ischlmia in the causation of this type of spinal nerve cell degeneration and no one will deny that even in cases which lack evidence of active inflammation, the arteries, arterioles and precapillaries are thickened, including the sulcal artery which supplies the anterior horns and, together with the branches from the circumferential arterial plexus, the lateral columns.
In this review of conditions characterized by motor nerve cell vulnerability, we are left with two groups which together constitute the amyotrophic lateral sclerosis syndrome proper. The first is composed of those 'degenerative' diseases with which it may be associated, namely Pick's disease (von Braunmuihl 1932 , Bertolini & d'Angelo 1925 , Parkinson's disease (van Bogaert & Radermecker 1954) and occasionally Kuru (Klatzo et al. 1959 ). There are also connecting links with familiar spinocerebellar degeneration with amyotrophy (Schut & Haymaker 1951). The second group includes the 'primary' formsthe classical (maladie de Charcot), the infantile, the Mariana type (Kurland & Mulder 1956 ) and with them we can conveniently include one variety of Creutzfeldt-Jakob disease (Meyer 1929 , Davison 1932 , namely that in which amyotrophy with fasciculation occurs and the so-called 'amyotrophic lateral sclerosis, with dementia'. The link with these last two equally obscure conditions suggests that we cannot exclude the presence of a toxin or of an acquired deficiency. The familial form certainly suggests an inherited trait but can environmental and particularly toxic factors always be excluded?
In spite of the fact that amyotrophic lateral sclerosis often develops at an age when arteriosclerosis may be expected and found, ischemia seems to be an unlikely cause; moreover, a local failure of blood flow in the spinal cord would not account for the selective and apparently primary involvement of neurones in the motor cortex and in the brain stem which characterize many instances of this disease.
We are therefore left in the dark as to the ctiology and pathogenesis of Charcot's disease, or perhaps group of diseases, but it clearly fits more into what we still have to call the primary degenerative disorders than into any other category. Whether the cells fail through want of a missing or blocked enzyme or even are destroyed by some process, it is impossible to say. Sixty years ago, Gowers (1902) placed this disease amongst the abiotrophies and for the time being we can, I believe, go no further than this.
N8v8ril J (1928) quoted by Colmant (1958) Kbh. 3, 391 Professor J N Cumings (Institute ofNeurology, London) Biochemical Aspects From 1955 From -1960 I have records of 28 patients adequately investigated, and in the past year the late Dr J Hamilton Paterson and I saw a further 13 cases. There is little difference between the two groups. Table 1 shows the age and sex distribution of the cases. I have omitted any acute bulbar cases. At least two in the, last group of 13 were private patients and this might be considered as indicating a slightly different type of distribution from that often recorded. One patient developed symptoms after gastrectomy. Table 1 also gives results in a few of the routine clinical pathological examinations made. The only abnormality to which special attention is directed is the erythrocyte sedimentation rate which was raised in 16 out of 35 patients. There was no correlation between this increase and the neurological abnormalities, or other biochemical abnormality, nor was any infective process present. Histamine test meals showed achlorhydria in only 4 of 20 patients. No serum enzyme abnormality has been found in this series: these enzymes have included alkalinei phosphatase, glutamic oxalacetic transaminase and lactic dehydrogenase. Liver function tests have also been normal.
The pyruvate metabolism test was abnormal in 15 of 36 patients; this was an unexpected finding for the patients were neither spastic nor immobile.
Recently it was decided to investigate amino acids, phenolic and indolic compounds in the urine. So far 8 patients have been examined; a marked aminoaciduria of over 200 mg of a amino acids a day was found in 6, in one case the figure being 904 and in another 730 mg a day. There was no correlation between the cases showing a raised aminoaciduria, raised erythrocyte sedimentation rate or abnormal pyruvic acid metabolism. The paper chromatograms showed evidence of aminoaciduria as is illustrated in Fig 1, and the presence of hydroxyproline is an abnormality which is being further investigated. Estimations of total hexosamine and acid mucopolysaccharide have been made on the skin of the 5 cases and on normal skin. No differences have been found between these two groups, for the total hexosamine has been 210 mg/100 g of dry normal skin while the corresponding figures for similar areas of abdominal skin from the 5 patients have ranged from 173 to 251 mg/100 g (average 203). No acid mucopolysaccharides were found in the skin of these patients.
We need, perhaps, to redefine the condition in order that chemical pathologistscan investigate it in a more reasonable manner. Suppose that the nerve cell were primarily at fault. Then, one could postulate that perhaps there was a primary abnormal mechanism involving nucleic acid metabolism. It might be that one enzyme system in the nerve cell was abnormal or was being poisoned by circulating substances in the body.
Perhaps we could, and I believe we should, if we had the financial facilities, be doing studies in this disease after the pattern of Professor H Hyden of Goteborg in his basic experiments, such as the estimation of ribonucleic acid and desoxyribonucleic acid and of their base composition products. At the same time, one could do autoradiographic investigations into the ribonucleic acid synthesis, as well as the site of this activity within the nerve cell. It may well be that the chemical pathologist should concentrate on working along these lines in the future. This outline of the electromyographic findings in motor neurone disease is presented in summarized form.
Spontaneous Activity
On inserting a sampling needle into an affected muscle, spontaneous activity of different kinds may be seen. fasciculation potential in more detail. The large amplitude, the long duration and the complex waveform are common features of motor unit potentials in this condition. Fasciculation visible through the skin over the muscle is due to spontaneous motor unit activity and is quite different from fibrillation in the sense in which the electromyographer uses the word. The distribution of such activity in widely separated muscles often serves to show that the lesion is not confined to nerve roots or to a single peripheral nerve. Fibrillation is not visible through the skin and is only detected by putting a needle into the muscle. It can, however, be seen occasionally in the tongue (Denny-Brown 1949) . Voluntary Activity Fig 3 shows the motor unit potentials recorded through a coaxial needle electrode on maximal voluntary effort. The upper trace shows them in a normal subject. There are so many units firing rapidly that it is not possible to see the individual components. The lower trace shows the effect of severe reduction in the number of units in motor neurone disease. Single units can be seen much more clearly than in the normal record.
When the disease has progressed so that only a single unit remains in the vicinity of the recording needle, such a unit may be seen discharging at a rate of 50-60 per second, which indicates that the patient is making a maximal voluntary effort. This appearance of a high discharge rate in a single surviving motor unit merely means that there is chronic partial denervation and it is not, of course, diagnostic of motor neurone disease, although it is seen very commonly in this condition.
Another common finding in motor neurone disease is an alteration in the size of the individual motor units. Surviving units are often of greater amplitude than normal. This is attributed to the incorporation of denervated muscle fibres into (Wohlfart 1958) . This finding has been amplified by Erminio et al. (1959) : using a multi-electrode they showed that the territory of motor units in motor neurone disease might be many times greater than in normal muscle.
In summary, the examination of voluntary activity reveals a reduction in the number of motor units under voluntary control which may be extreme. Surviving units are often larger than 
Motor Conduction Velocity
Fig 4 illustrates the method of estimation of motor conduction velocity. In this instance, the ulnar nerve was stimulated at the wrist and at the elbow. When the nerve is stimulated at the wrist the stimulus artifact is followed after a short interval by the onset of the muscle action potential recorded from abductor digiti minimi. In the STIMULUS AT case of stimulation at the elbow, the muscle action potential follows the stimulus artifact after a longer latency. By subtraction of the shorter latency from the longer, it is possible to calculate the time taken for the volley of impulses to pass down the motor fibres between elbow and wrist. second. Thus, estimation of motor conduction velocity is useful in that chronic polyneuritis can often be distinguished from motor neurone disease in this way.
Nerve Action Potentials
The recording of nerve action potentials (Dawson & Scott 1949 , Dawson 1956 shows that there is no abnormality of conduction in sensory fibres in motor neurone disease. In the arm, we use the technique developed by Gilliatt & Sears (1958) to demonstrate this (Fig 7) . On stimulation of the digital nerves, nerve action potentials may be recorded from median and ulnar nerves at the wrist. In motor neurone disease, such potentials are normal.
In the leg, it is not possible to record action potentials derived solely from sensory fibres because of the small number of fibres in the digital nerves. To record action potentials from the lateral popliteal nerve, it is necessary to stimulate the anterior tibial nerve at the ankle, which contains the motor fibres to the extensor digitoruin brevis as well as sensory fibres (Gilliatt et al. 1961) . potential recorded from lateral poplitea median and ulnar nerves of the wrist in a healthy subject. nerve in patient with motor neurone disease. 100 sweeps Stimulation of the index and littlefingers. Tracings show superimposed. Stimulus to ant. tibial nerve at ankle. stimulus artifact followed by triphasic action potential. Stimulus artifact followed by triphasic action potential. Time scale I and S msec; 20 sweeps superimposed. Calibration 5 V. B, recording from extensor digitorum (Reproduced from Gilliatt & Sears, 1958 , by kind brevis simultaneous with A to show absence of muscle permission) action potential. Calibration 500 IuV fibula. The electrodes over the extensor digitorum brevis serve to monitor the motor response. Fig  9 shows the result in a patient with motor neurone disease. The stimulus used gave rise to a nerve action potential (upper trace) which was of normal amplitude. One hundred sweeps are superimposed. The lower trace is the record from surface electrodes placed over extensor digitorum brevis. No electrical activity is seen in the muscle, and from this we conclude that the motor fibres were completely destroyed by disease but that sensory fibres were functioning normally. Table 1 shows the results which we found in 5 patients with motor neurone disease who were chosen because extensor digitorum brevis was nearly completely atrophied in each case. Thus, motor nerve fibres were making no contributioD to the nerve action potentials shown in the righthand column. This illustrates the preservation of sensory function which we find in this condition.
The importance of this recording technique is that it enables us to distinguish motor neurone disease from muscle wasting due to polyneuritis or diabetic amyotrophy, which sometimes gives rise to considerable difficulty in diagnosis. In diabetic patients (Gilliatt & Willison 1962) we have usually found defects in sensory conduction even if sensation has appeared to be preserved on clinical testing. As we have heard, motor neurone disease is generally said to have a prognosis of from two to four years. I was interested in those patients seen at the National Hospital, Queen Square, who lived longer and others who showed particular features in a search for clues to possible wtiological factors in certain forms of the disease (Table 1 ).
The period under study was 1948 until the present time. All the patients suffered from disease of the motor neurone. Disease of the motor neurone in patients with previous history of anterior poliomyelitis 11 5
Other patients with motor neurone disease 110 ,Group 1: Seven patients presented the clinical picture of progressive muscular atrophy and sur-*vived ten years or more. Three patients died 10, 11 and 13 years from the onset and four are alive 11, 14, 14 and 15 years from the onset of the disease. Five patients had absent tendon reflexes and two showed diminished tendon reflexes when they were first seen two to three years from the onset.
All 7 patients showed marked and scattered -fasciculation during their repeated admissions to 'Lately Resident Medical Officer, The National Hospital, Queen :Square, London hospital. The other constant finding in this group was the absence of any clinical evidence of an upper motor neurone lesion. The only bulbar sign present was fasciculation of the tongue in 3 of the patients. Three other patients presented with distal wasting in the legs and arms. These cases were the most difficult to differentiate from a purely motor polyneuritis of undetermined cause and from peroneal muscular atrophy. The negative family history, the marked fasciculation, the absence of sensory loss and electrical conduction studies were all helpful in reaching the diagnosis.
In all 7 cases the EMG and muscle biopsy showed a picture of chronic denervation. The C.S.F. protein and the pyruvate tolerance test were normal in all these patients.
From the point of view of prognosis it was important to recognize these cases, and if after two years a patient with motor neurone disease still shows no upper motor neurone signs, then there is a good chance of a relatively benign course. Fasciculation of the tongue was not an ominous sign in this respect in this group of patients. Muller (1952) arrived at very much the same conclusion in reviewing the cases in Sweden.
Group 2: Four patients presented with the clinical picture of chronic spinal muscular atrophy from early childhood. The illness started between 1 and 4 years of age, and the patients are now 16, 36, 37 and 37 years old. They all showed marked and extensive fasciculation from the onset, and two of the patients also had fasciculation of the tongue. All 4 have lost their tendon reflexes and are chairridden. They have coped surprisingly well despite their severe disability. There was no family history of neurological disease. Two of the patients died, three and seven years from the onset of amyotrophy, one of them from intercurrent disease. The remaining three patients are alive, two, four and eight years from the onset.
Four of the 5 patients showed progressive wasting, and one is deteriorating rapidly after two years with the picture of amyotrophic lateral sclerosis.
Two of the patients gave a history of encephalitis and one of them of oculogyric crises. The onset of parkinsonism was at a comparatively early age. All 5 patients showed a marked defect of convergence of the eyes; and as well as their tremor and rigidity there was definite wasting and fasciculation. The picture in these cases was very much as described by in their two cases.
Group 4: The most interesting group of all is that of patients presenting a picture of apparently active disease of the motor neurone and who gave a definite history of paralytic anterior poliomyelitis before the age of 6 years. In every patient there was residual weakness, wasting and shortening of at least one limb. Then after an interval of seventeen to forty-three years, during which time they carried on with normal activity, all 11 patients complained of a noticeable weakness in another limb not previously involved. Ten patients are still alive one to eleven years from the onset of the new illness, and one patient died five years from the onset of the new illness.
As well as progressive wasting, all patients showed marked and scattered fasciculation. The limb previously affected by poliomyelitis had also become weaker, but this was not as noticeable to the patient as the involvement of the other limbs.
The 10 surviving patients show a variable degree of deterioration with a predominant picture of slowly progressive muscular atrophy and without any bulbar symptoms or signs. Five of the patients had an extensor plantar response on one or both sides. The eleventh patient showed increased tone in all his limbs with exaggerated reflexes and he died from respiratory failure.
Consideration was given to the actual recorded incidence of paralytic poliomyelitis in children up to the age of 6 years from 1925 to 1935, during which period these patients had their attack of poliomyelitis; and to the recorded incidence of motor neurone disease in the age group 30-55, the age group of these patients. From this it was calculated that one would expect one case of motor neurone disease with a previous history of poliomyelitis to turn up in the whole of England and Wales every thirty-nine years. And yet in a period of thirteen years at Queen Square alone, there were 11 cases with a past history of poliomyelitis and recent progressive lesion of the motor neurone.
Professor G Payling Wright has kindly looked at the epidemiological statistics with me, and unless there is a gross error in the recorded incidence of motor neurone disease in recent years and the previous recorded incidence of paralytic poliomyelitis in England and Wales, any association of the two diseases must be regarded as very striking.
It could be suggested that the subsequent development of disease of the motor neurone in those patients with a previous history of poliomyelitis, usually twenty-five years before, is related to the occurrence of that earlier disease.
Very few patients suffering from motor neurone disease give a definite past history of poliomyelitis, only about 1 in 10 in the present collection of cases, but one should search further into the illnesses of childhood in patients with motor neurone disease to assess this relationship.
Group 5: There were 110 other patients with very probable motor neurone disease, but few of them had post-mortem examinations at the hospitals where they eventually died.
Another 120 cases of possible motor neurone disease, seen at Queen Square during this period of time, were not included because the diagnosis was not sufficiently definite, particularly where there was conflicting evidence of muscle biopsy and EMG and where cervical spondylosis was present and giving rise to symptoms. I add my plea for more post-mortem studies of the nervous system in all these patients, in whichever hospital they die.
Postscript (25.10.62): The phospholipids were estimated in the cerebrospinal fluid of two of the patients with a previous history of paralytic poliomyelitis and more recent progressive wasting and weakness. In both cases there was a raised total phospholipid content and a relative increase in the proportion of cephalin, suggestive of progressive degeneration of nervous tissue (McArdle & Zilkha 1962) . -K J Z.
Professor J'N Cumings: I believe it is not uncommon in some cases of poliomyeli'tis for an opposite limb to be affected in a muscular disorder. I certainly have seen a case in which the opposite leg has been affected by muscular dystrophy following poliomyelitis affecting on leg. Can Dr Spillane suggest why the opposite leg is involved and not the leg already affected by poliomyelitis?
Dr Spillane: I have no idea at all. I have known the story since Collier first put it forward in the English literature many years ago, but I have never actually seen it. I suppose we are only beginning to know what the virus can do. There is no doubt that a virus can persist in the human body for many years. Whether a virus can lie dormant and produce a chronic poliomyelitis thirty years later, as these clinical studies suggest, or why it should cross to the other leg, I cannot say.
Dr McMenemey: Is it suggested that the additional strain on a limb may contribute to the subsequent disease in it? Dr Macdonald Critchley: I have seen motor neurone disease after poliomyelitis several times. In my experience, it is the wasted leg that begins to worsen. Then the trouble spreads to other segments, and then across to the other side.
Dr Denis Williams (London): May there not be in such instances an error of observation on the part of the patient rather than of the physician? A weakness may have been present in some degree ever since the infection.
Dr R S Allison (Belfast): I agree with what has been said by some of the speakers. I have two cases, both coming to post-mortem, of proved motor neurone disease with a history of poliomyelitis many years before. So we should refer patients with motor neurone disease to the virus laboratory when there is a history of former poliomyelitis, in the hope that there may be some evidence in antibody reactions to suggest a reactivation.
Dr L A Liversedge (Manchester): This important observation is, in one way, rather alarming. It has been implied that ifwe question patients with motor neurone disease carefully, we shall find that many of them had some time in the past had a subclinical attack of poliomyelitis, and Dr Spillane has suggested that the poliovirus may lie latent within the nervous system for many years before becoming reactivated to produce motor neurone disease.
At the moment, the health authorities of this country are on the point of distributing large quantities of live polio vaccine. If these observations are further supported, it seems very important that we should take them into account, in deciding whether the polio vaccination pro-50 gramme should be carried out with dead vaccine or live vaccine. I wonder whether we can contemplate with equanimity the idea that we may be introducing in the population a virus which may lurk unnoticed for many years and then show itself in this tragic fashion.
Dr Zilkha: May I add to what Dr Critchley and Dr Denis Williams have said? In the 11 patients who gave a previous history of poliomyelitis the limb previously affected was again severely affected, and showed marked fasciculation.
Professor Cumings: None of my 41 cases was formerly affected by poliomyelitis. Dr Purdon Martin (London): For many years I have known the story of amyotrophic lateral sclerosis developing in subjects who have had poliomyelitis, but I have never seen it. I do not believe that any virus persists, but what does persist is fasciculation. In several instances I have seen patients who have had poliomyelitis years before appear with fasciculation, and I have seen patients who have had poliomyelitis and who have gone on fasciculating for years. I notice that all the poliomyelitis patients are still alive, except one. I have followed some of these patients for several years and I have not seen any wasting. All that they have is fasciculation. They have been sent to me as cases of amyotrophic lateral sclerosis.
Dr Willison: My impression from examining patients with long-standing poliomyelitis is that when their motor units have been enlarged by incorporation of muscle fibres previously innervated by cells destroyed in the acute illness, they are in a very bad position to lose any motor nerve cells in later life. It would be interesting if Dr McMenemey could give us an indication of the normal rate of dropping out of motor neurones from early life onwards, because this might well be an answer to the problem of deterioration of muscular strength years after the illness.
Dr McMenemey: I think that any such loss must be small, and not really anything that one could readily recognize in a qualitative sort of way. There are very few standard works on this subject.
Professor P C P Cloake (Birmingham): I have seen muscle wasting develop years after an attack of poliomyelitis. What I have not had the opportunity of observing is whether this muscle wasting develops in any kind of series of muscles sug-gested by the classical motor neurone disease. No one has said that he has seen motor neurone disease in classical form in a patient with say, a wasted leg from poliomyelitis developing, for example, muscle wasting in the hands.
I have always felt that in poliomyelitis, many cells which actually survive have been damaged and that long afterwards the normal stresses of life, or what we imagine to be progressive senility in the cell, begin to appear first in those cells which already have been damaged in the past by poliomyelitis.
I should like to ask if anyone has seen progressive muscular atrophy develop in full classical form after poliomyelitis?
Dr Michael Ashby (London): I am diffident in disagreeing with Dr Spillane about the matter of frequency. I have noticed in my own practice quite a sharp increase in motor neurone disease in the past three or four years. I do not know its significance.
I was interested to see Dr A M G Campbell's letter (Brit. med. J., 1962, i, 938) referring to the increase in motor neurone disease. I wonder whether it might help if any other members of the audience could mention their experiences, or possibly whether the Association of British Neurologists and this Section might work together and consider whether one of us might volunteer to keep a record of these patients. As they deteriorate they frequently seek another opinion. We need a central register if we are going to get the figures right.
Dr Pratt: If that should happen, there should be undertaken a fairly simple standard genetical enquiry. Many separate families have been described, but there have been too few properly genetically investigated series of patients with classical motor neurone disease.
Dr Katherine M Levy (Edinburgh): My experience of the genetic aspects of motor neurone disease is based upon a small series, consisting of those patients referred to the Northern General Hospital and the Royal Infirmary, Edinburgh, during the years 1954-60.
In all cases, the diagnosis of motor neurone disease had already been made by a neurologist. For the purposes of this enquiry, however, very strict diagnostic criteria were laid down, so that only cases conforming strictly to the 'classical' description of the disease were accepted. Out of a possible total of 56 cases, 22 (39 3%Y.) were rejected by the appropriate neurologist, leaving a final series of 34 cases, 21 males and 13 females.
All the patients were interviewed personally, or, if they had died, their relatives were interviewed. Often both patient and relatives were interviewed, so that a full family history was obtained in each case. The causes of death for all immediate relatives of propositi were confirmed if possible, either from death certificates or from hospital records.
Results
(1) The average age of onset of the disease was 56 6 years: the age range was 28-74 years.
(2) Males were affected more frequently than females in the ratio 1 62: 1.
(3) There was no parental consanguinity. (4) There was no birth order effect. (5) 3 patients (8 8%) gave a family history of motor neurone disease: 2 female patients and 1 male. (6) Of the 18 parents, 3 were affected, 2 mothers and 1 father. (7) Of the 148 sibs, 75 male and 73 female, 1 female sib was affected. (8) There was no clear history of any precipitating factors, although all patients, or their relatives, were asked specifically about them. There was no history of previous trauma, or of anterior poliomyelitis, nor were there any associated neurological or psychiatric disorders. (9) In 3 cases, however, there was an association with peptic ulcer. In one, perforation of a peptic ulcer was the immediate cause of death: in the second, symptoms developed four days after partial gastrectomy for peptic ulcer: in the third, symptoms developed a year after partial gastrectomy for a perforated peptic ulcer. (10) One further point, which I have not seen mentioned elsewhere, was the high incidence of cancer of the gastro-intestinal tract as a cause of death in the parents of propositi. In this series, 6 mothers and 4 fathers, 14 6 Y of all parents, are known to have died of a gastro-intestinal carcinoma. If unconfirmed cases are includedthat is, cases for whom the cause could not be confirmed objectivelythe total is nearer 25 %. This compares with 12 05 % found by the Registrar General for Scotland (1933) , for a comparable population. I would suggest that: (1) Genetic factors play some part in the causation of motor neurone disease in its 'classical' form.
(2) From a small series such as this, it is possible to make only the most tentative suggestions as to the extent and 52 nature of the genetic factors involved. It would appear that these factors operate in about 9 % of cases and that the mode of inheritance is that of a dominant with incomplete penetrance.
Dr H L Hoffman (Bath): May I bring up the time-honoured question of the effect of trauma in the precipitation of this condition, especially trauma in the primarily affected limb? In a small series of 25 unselected cases I found that 4 had received some significant trauma to the primarily affected limb in the six months preceding the onset of the condition, such as crushing ofa finger, fracture of the tibia, a piece of scenery dropped on a foot and severe sprain of the wrist, sufficient to bring the patient to hospital. Some of these people have developed wasting almost immediately after their injury, and all within six months. Dr Spillane: In our wards in Cardiff, the chances of a man with progressive muscular atrophy being a labourer are high, and the chances that he has had trauma are high also. Details of the trauma are usually easily elicited. In a court of law, nobody can prove that the disease was there before, but I have never seen a case in which I thought that a clear-cut relationship was established between trauma and the onset of the disease.
A retired colleague often told me of his belief that Collier was right about the association of poliomyelitis and this disease. He often called me up to his ward and showed me the fibrillating thigh of a person who had had poliomyelitis as a child.
But, like Dr Martin, I have never seen those cases progress. Unless somebody can produce more evidence than we have had of the association between poliomyelitis and progressive muscular atrophy, the evidence is inconclusive. If those cases which die are proved to have had poliomyelitis and to have died of progressive muscular atrophy, this would be something most important.
Professor Cumings: Can Dr Willison distinguish between poliomyelitis and motor neurone disease by their electrical reactions? Dr Willison: I have seen a few cases of old poliomyelitis that have been offered as cases of motor neurone disease, and it is difficult to make any contribution to the diagnosis. The electrical picture on examining muscle and conduction velocities are much the same in the two conditions.
The only thing that one would have to go on in this situation is the distribution of lesions. In examining cases of poliomyelitis, it is very difficult to be quite sure that mild electrical changes in the muscle were not, in fact, due to the old disease. So electromyography cannot help very much. Dr Martin: Can Dr McMenemey tell us whether the gliosis in the poliomyelitis case would produce some further effects that might lead to a slight further degree of wasting by reduction in the number of nerve cells or otherwise? Dr Spillane: I have never seen motor neurone disease following encephalitis, but I have known such a diagnosis made although I learned that the patient's brother had a similar condition of parkinsonism and gross amyotrophy.
Following Dr Critchley's remarks, what about electric shock? We all know of cases in which there is electric shock followed by progressive muscular atrophy. What is the implication? Has. it been shown that electric shock in a normal person can start this process, or is there an acutecervical cord lesion with initial destruction. resulting in amyotrophy? Is it motor neuronedisease ? Dr Critchley: There are two relevant conditions. after electric shock. When a shock passes from one hand, up the arm, across and out of the other arm, the patient is liable within a few weeks to develop what Panse (1930) described as 'spinal atrophic palsy', a picture in which there is wastingand fasciculation of the upper limbs with some degree of spasticity of the lower limbs. But I do not believe that those cases progress very far. I think that they reach a certain level and then. stop.
Panse originally described 29 such cases and then added to them later. But over and abovethose 'spinal atrophic electrotraumatic' cases, I still think that there is another group of cases in which peripheral trauma seems to be of aetiological significance to the development of amyotrophic lateral sclerosis. I refer to those cases of electric shock where within a matter of weeks or, perhaps, a month or two, the patient shows wasting of the injured segment, which spreads and then develops. There are signs which go on to a full-fledged picture of amyotrophic sclerosis. But the commoner of the two are the non-progressive cases described by Panse.
Nothing has been said about the possible role in etiology of a previous habit of athleticism. I have the uncomfortable feeling that a past history of unnecessary muscular movement carried out for no very obvious reason may be followed in later life by the development of motor neurone disease in a statistically significant number of cases.
There is the notorious case of the baseball player in the United States, and in America, of course, this disease is not called motor neurone disease. It is called Lou Gerig's disease. This may be more than a coincidence, and I would welcome the views of experienced clinicians as to whether they think that there is substance in it. Dr Spillane: I know an ex-weight lifter who developed it. This was discovered by a houseman of mine, who was interested in the observation that the average male case is not a clerk who sits in an office but is a heavy labourer. On one ward round we came across a man who was a clerk, but he was also an ex-champion weight lifter! Dr C J Earl (London): One interesting point about this condition is that the external ocular muscles are entirely spared. This is so even when, as often happens, every other muscle in the body is involved. It is hardly likely that a defect in ocular movement would pass unnoticed where the slightest degree of muscular weakness will give rise to diplopia. I wonder whether Dr McMenemey might have anything to offer on the pathological side. It might be possible to see whether there is any difference between the involvement of the VI and VII nuclei. The two lie close together and affection of the facial muscles is quite frequent.
REFERENCE
Dr McMenemey: Dr Martin referred to the possibility of gliosis itself being a cause of motorneurone disease in patients who have had poliomyelitis. Gliosis may be expected to reach its maximum degree after about six months, but -there are other possible factors such as secondary changes in the spinal blood vessels. Therefore I suppose that theoretically it is possible for sur--viving anterior horn cells to atrophy years later as -a result of the reparative process, but I think it is -unlikely. Dr Earl raised a point about the cranial nerve nuclei. Most authorities agree that they are rarely involved but they differ over the question of the frequency with which the facial nucleus is affected. Some have said fairly often, others have said rarely. The selective sparing of the VI as against the VII nerve nucleus suggests that factors intrinsic to the latter account for its vulnerability, rather than any peculiarities of blood supply. I mention again the question of continuing infection in post-encephalitic parkinsonism with amyotrophy. We have heard of these cases and our experience, which agrees with that of Dr Matthews and of the late Dr Greenfield, suggests that it may be part of the original infection and not another disease developing independently afterwards. Therefore these cases should not be labelled 'amyotrophic lateral sclerosis'. Motor neurone disease, in the broader sense of the term, it may be, but I think that the disease process is secondary to, and may be a continuation of, the original disease.
With regard to the cases of poliomyelitis which appear to smoulder on for a long time, is it not possible that the virus, having found itself in a very choice spot, decides to remain on in a state of parasitism rather than kill the host cell? We think of viral infections as self-limiting diseases, but there may be more exceptions to this generalization than we realize. Many of the cells are destroyed at once, and of this fact there is no doubt, but perhaps in some of them a state of symbiosis is reached. Then, for some unknown reason, later on in life the infection may gradually build up again and other cells become slowly implicated. The position with regard to amyotrophy developing years after poliomyelitis may then be similar to that following von Economo's disease, although the viral origin of the latter has never been proven.
I agree with Dr Pratt and Professor Cumings that further research in this field is badly needed. I hope that as a result of this meeting some sort of registry will be formed, because this would constitute an important first step. The President: Although the incidence of motor neurone disease certainly seems to be increasing, there are at times diagnostic doubts about some patients. In view of the very grave prognosis, there is always a tendency, conscious or unconscious, to abandon to his fate any patient to whom this diagnosis has been given. It seems extremely important, therefore, never to attach this particular label until the diagnosis of motor neurone disease is established beyond aU doubt. 
